Baxter International | BAX - 当期純利益





当期純利益 変化する 日付
Abbott USD 928M 149M 2026-06
AngioDynamics USD -6.35M 4.55M 2025-09
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 8.96M 8.85M 2026-06
Baxter International USD 126M 141M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Boston Scientific USD 907M 434M 2026-06
Cooper Companies USD 432.8M 510.7M 2026-06
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Fresenius EUR 382M 53M 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
ICU Medical USD 19.09M 11.04M 2026-06
Inogen USD -5.96M 373K 2024-09
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
Intuitive Surgical USD 818.1M 3.4M 2026-06
J&J USD 5.53B 299M 2026-06
Laboratory Of America USD 298.7M 20.9M 2026-06
Medtronic USD 1.47B 227M 2026-06
Merit Medical Systems USD 41M 2.99M 2026-03
Quest Diagnostics USD 320M 69M 2026-06
Smith & Nephew USD 303M 10M 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teleflex USD 99.69M 107.85M 2026-06
Terumo JPY 70.43B 44.06B 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06